It is worth noting that the HER2+/ERα+ breast cancer cells (MDA-MB361) are more sensitivity to USP15 knockdown than HER2+/ERα- breast cancer cells (SK-BR3) (Supplementary Fig. 1). This evidence concerns the gene ERBB2 and breast cancer.